Akili shares rise after early data shows video game treatment can improve attention in adults

The company aims to expand its video game-based treatment for ADHD to adults and adolescents. 

By Elise Reuter • May 4, 2023

FDA posts draft guidance on studying medical devices in decentralized clinical trials

Analysts at Cowen said the draft could reassure sponsors they can run decentralized trials without complicating approvals.

By Nick Paul Taylor • May 4, 2023

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Tandem expects to meet ‘key’ goals even as rival’s device launch may curb short-term sales growth

Tandem claims it has a better insulin pump than Medtronic’s recently approved rival MiniMed 780G device.

By Nick Paul Taylor • May 4, 2023

Thermo Fisher plans another round of layoffs in California, as profits fall

The workforce reductions at the scientific instruments maker continue the wave of job cuts affecting the medical device sector in recent months.

By Susan Kelly • Updated May 3, 2023

Dexcom proposes $1.1B debt offering to add to existing $2.6B cash reserve

About $189 million of the funds will go toward the repurchase of Dexcom stock and a portion will support other financial transactions, the company said.

By Nick Paul Taylor • May 3, 2023

Medtronic’s US diabetes business is floundering. Can the MiniMed 780G rescue it?

The company, sidelined by a warning letter while competitors brought new products to market, is counting on its newest diabetes devices to spur “pent up interest.”

By Elise Reuter • May 2, 2023

Masimo suit against Apple over smartwatch trade secrets ends in mistrial

The medical device maker said it intends to retry the lawsuit, as it awaits a decision from the International Trade Commission on a separate investigation into patent infringement claims against Apple.

By Susan Kelly • May 2, 2023

Zimmer Biomet grows revenue, profits, as orthopedic procedures return

CEO Bryan Hanson said “pretty much everything went better than expected” in the first quarter. 

By Elise Reuter • May 2, 2023

Analyst ‘blown away’ by robot-fueled growth of Stryker’s hip and knee sales

Stryker CEO Kevin Lobo named the Mako robot as a driver of “pretty breathtaking” knee growth outside the U.S.

By Nick Paul Taylor • May 2, 2023

Hologic, after overcoming chip shortage, starts considering larger M&A deals

The breast health unit “emphatically returned to growth” because of improvements to the supply of semiconductors.

By Nick Paul Taylor • May 2, 2023

Medtronic ramps up competition for leadless pacemakers with newly approved devices

Medtronic received FDA approval for the first leadless pacemaker in 2016, but faces a new competitor in Abbott, which got the nod for its own leadless device last year.

By Elise Reuter • May 1, 2023

Great Britain proposes allowing CE marks until 2030 to minimize Brexit disruption

The extended timeline to create a new regulatory system in England, Scotland and Wales is intended to prevent medical device shortages.

By Nick Paul Taylor • May 1, 2023

Globus shareholders approve share issuance for $3.1B NuVasive purchase

NuVasive’s shareholders also OK’d the merger agreement, bringing the deal a step closer to closing.

By Elise Reuter • April 28, 2023

Dexcom reports ‘growing momentum’ behind G7 launch in first quarter

The CGM launch helped the company add more users than in any other quarter in its history.

By Nick Paul Taylor • April 28, 2023

ResMed device sales jump 43% as supply constraints ease

ResMed’s CEO said “I know we’ll be able to beat [Philips]” when the rival returns to the market after its recall.

By Nick Paul Taylor • April 28, 2023

Illumina gets cybersecurity warning from FDA over sequencing software

The vulnerability could result in an attacker gaining control of an instrument remotely and altering genomic data results, the agency said.

By Susan Kelly • Updated April 28, 2023

3M plans 6,000 layoffs as hospital staffing woes continue to curb procedures

Manufacturing and supply chain “headwinds” hurt operating margins in the first quarter, the company said.

By Peter Green • April 27, 2023

Edwards Q1 revenue boosted by growth at TAVR unit, surgical structural heart business

The company also said it benefited from improved hospital staffing levels that led to a rebound in procedures.

By Nick Paul Taylor • April 27, 2023

Boston Scientific Q1 sales top expectations on ‘healthy’ market demand

As medical procedures pick up pace after the COVID slowdown, the company said it is taking market share in all of its business units.

By Susan Kelly • April 26, 2023

Thermo Fisher reports 9% drop in Q1 revenue, shares slip

The drop in revenue accompanied a 41% decline in net income, with Life Sciences Solutions and Specialty Diagnostics revenue declining by double digits. 

By Peter Green • April 26, 2023

Insulet gets FDA clearance for tubeless pump to eliminate daily shots for basal insulin users

The device, called Omnipod GO, eliminates the need for daily injections for people with Type 2 diabetes, CEO Jim Hollingshead said.

By Elise Reuter • April 25, 2023

GE HealthCare revenue up in first quarter as a standalone company, but shares drop

Steady demand and supply chain improvements have helped it grow the business, even as inflation and foreign exchange rates pressure its income.

By Elise Reuter • Updated April 25, 2023

Know Labs hopes to advance non-invasive glucose sensor with proof-of-concept test

The company wants to use its Bio-RFID technology for glucose monitoring, and recently showed the device could detect and quantify specific molecules in water. 

By Nick Paul Taylor • April 25, 2023

Philips says revenue rises 6%, sees €575M in recall-related legal costs

CEO Roy Jakobs expressed confidence in the company’s outlook for the year ahead and said setting aside the funds to resolve a U.S. class action lawsuit was “an important step.”

By Susan Kelly • April 24, 2023

Graphene ‘tattoo’ pacemaker senses and treats irregular heart beats in rats

While still in early stages of development, the tattoo material can mold to the heart, unlike the more rigid implanted pacemakers used today, reducing some of the problems with traditional and leadless technologies.

By Nick Paul Taylor • April 24, 2023